Santoprete; Alessia
Patent Applications and Registrations
Patent applications and USPTO patent grants for Santoprete; Alessia.The latest application filed is for "modified lipidated relaxin b chain peptides and their therapeutic use".
- Santoprete; Alessia - Rome IT
- SANTOPRETE; Alessia - Pomezia RM
- Santoprete; Alessia - Pomezia IT
- Santoprete; Alessia - Pommezia IT
| Patent | Date |
|---|---|
| PCSK9 antagonists bicyclo-compounds Grant 11,306,125 - Xiong , et al. April 19, 2 | 2022-04-19 |
| Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20210292387 - DUCLOS; Olivier ; et al. | 2021-09-23 |
| Cyclic Polypeptides For Pcsk9 Inhibition App 20210284694 - Ricardo; Alonso ; et al. | 2021-09-16 |
| Pcsk9 Antagonists Bicyclo-compounds App 20210214395 - Xiong; Yusheng ; et al. | 2021-07-15 |
| Modified lipidated Relaxin B chain peptides and their therapeutic use Grant 10,988,523 - Brasseur , et al. April 27, 2 | 2021-04-27 |
| Modified relaxin B chain peptides and their therapeutic use Grant 10,988,524 - Illiano , et al. April 27, 2 | 2021-04-27 |
| Modified lipidated Relaxin B chain peptides and their therapeutic use Grant 10,961,295 - Duclos , et al. March 30, 2 | 2021-03-30 |
| Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20190233494 - DUCLOS; Olivier ; et al. | 2019-08-01 |
| Modified Relaxin B Chain Peptides And Their Therapeutic Use App 20190233495 - ILLIANO; Stephane ; et al. | 2019-08-01 |
| Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20190233493 - Brasseur; Denis ; et al. | 2019-08-01 |
| Oxyntomodulin analogs Grant 9,593,155 - Carrington , et al. March 14, 2 | 2017-03-14 |
| Oxyntomodulin Analogs App 20120165503 - Carrington; Paul E. ; et al. | 2012-06-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 